Rigel PharmaceuticalsRIGL
13F holders, Q3 2025 (September 30)6holders +1
2new positions
1sold out
$28.33avg. 13F price*
At the end of Q3 2025, 6 institutions reported holding Rigel Pharmaceuticals Inc. (RIGL) in their 13F filings, up 1 from Q2 2025. 2 opened new positions and 1 sold out. The largest holders were Advisory Services Network, LLC ($899K), Farther Finance Advisors, LLC ($21K) and Versant Capital Management, Inc ($6K).
- Company
- Rigel Pharmaceuticals Inc.
- CUSIP
- 766559603
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q2 2025 → Q3 2025
| Institutions | Total Value | |
|---|---|---|
| New Positions | 2 | $902K |
| Exits | 1 | $187 |
All 13F filers, Q2 2025 → Q3 2025: 31,853 shares bought and 11 shares sold, net +31,842 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 6 holders
| Advisory Services Network, LLC | 0.01% | New | 31,721 | $899K |
| Farther Finance Advisors, LLC | 0.00% | Add +1.1% | 730 | $21K |
| Versant Capital Management, Inc | 0.00% | Reduce -0.4% | 224 | $6K |
| LRI Investments, LLC | 0.00% | New | 124 | $4K |
| Essential Partners LLC | 0.00% | No change | 3 | $85 |
| Huntington National Bank | 0.00% | No change | 1 | $1 |
"% of holder's portfolio" is RIGL's weight in each manager's 13F, not the share of Rigel Pharmaceuticals Inc. the manager owns.